Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The homepage now states ClinicalTrials.gov hosts 593,334 studies across all 50 states and 226 countries and territories, updating the stated total to reflect current scope.
    Difference
    0.1%
    Check dated 2026-07-11T00:37:55.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The homepage now shows 592,210 studies with locations in all 50 states and 226 countries and territories, and it displays Revision: v3.6.3, updating the database size and version on the site.
    Difference
    0.3%
    Check dated 2026-07-03T22:09:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The homepage now reports 591,437 studies across all 50 states and 226 countries, replacing the previous figure of 590,354. The site revision line updates from v3.6.0 to v3.6.2.
    Difference
    0.3%
    Check dated 2026-06-26T23:51:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The homepage blurb now shows 590,354 studies with locations in all 50 states and in 226 countries and territories. This replaces the previous count of 589,453 studies.
    Difference
    0.9%
    Check dated 2026-06-19T22:58:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    New homepage sections provide direct links for How to Search for Clinical Studies, Common Questions, How to Join a Study, and For Patients and Caregivers, improving user guidance. The site-wide stat is updated to 589,453 studies with locations in all 50 states and 226 countries and territories, replacing the previous worldwide phrasing and updating the revision version to v3.6.0.
    Difference
    0.9%
    Check dated 2026-06-12T16:43:01.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.5.4 to v3.5.5, indicating a new site release.
    Difference
    0.1%
    Check dated 2026-06-05T13:26:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.